Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01LYX
|
||||
Former ID |
DIB009619
|
||||
Drug Name |
Eptastigmine
|
||||
Synonyms |
Epiastigmine; Eptastigmine tartrate; Heptylstigmine tartrate; Heptyl-physostigmine; L-693487; MF-201
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 3 | [526265] | ||
Company |
Consiglio Nazionale delle Ricerche
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H33N3O2
|
||||
Canonical SMILES |
[C@]12([C@@H](N(c3c1cc(OC(=O)NCCCCCCC)cc3)C)N(CC2)C)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [526265] | |
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.